Silver Book

Silver Book Fact

Over 8 years infection control practices saved ~27,000 lives and $1.8 billion

Infection control practices saved an estimated 27,000 lives and $1.8 billion in medical costs between 2001 and 2009.

Frieden T, Khabbaz R. A CDC Framework for Preventing Infectious Diseases: Sustaining the essentials and innovating for the future. Atlanta, GA: Centers for Disease Control & Prevention; 2011. https://stacks.cdc.gov/view/cdc/11695

Reference

Title
A CDC Framework for Preventing Infectious Diseases: Sustaining the essentials and innovating for the future
Publisher
Centers for Disease Control & Prevention
Publication Date
2011
Authors
Frieden T, Khabbaz R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value

Publications

Healthcare-Associated Infections Factsheet

 https://www.silverbook.org/wp-content/uploads/2015/06/Screen-Shot-2015-06-30-at-3.02.28-PM.png Thumbnail

Related Facts

  • Only a 20% reduction in drug-resistant infections would save $3.2 – $5.2 billion each year
    A 20% reduction in drug-resistant infections would save between 5.7 and 11.3 million additional hospital days and between $3.2 and $5.2 billion in healthcare costs, each year.  
  • Negative value of antibiotics to drug companies
    The value of an antibiotic to a drug company is negative $50 million- compared to the positive value of $1 billion for a new musculoskeletal drug.  
  • Infection control program reduced hospital-acquired HAIs by > 1/3
    A multimodal infection control program reduced the rate of hospital-acquired HAIs by more than 1/3 and improved quality of care and patient outcomes.  
  • Over 8 years infection control practices saved ~27,000 lives and $1.8 billion
    Infection control practices saved an estimated 27,000 lives and $1.8 billion in medical costs between 2001 and 2009.  
  • An antibiotic stewardship program saved $17 million over 8 years
    An antibiotic stewardship program saved a total of $17 million over 8 years, with antibiotic costs rising $1 million in the first year after discontinuation.